High Court Recusals Questioned After Split Rulings
Law360 (March 4, 2008, 12:00 AM EST) -- Chief Justice John Roberts' recusal from participating in a recent U.S. Supreme Court decision, preventing what would have been a decisive vote in a product liability suit against Pfizer Inc., has renewed concerns about the high court's recusal process.
As a result of the 4-4 split by the remaining justices overhearing the case, the Supreme Court affirmed a lower court's ruling allowing Michigan residents to advance claims against Pfizer unit Warner-Lambert over the diabetes drug Rezulin. An evenly split court automatically upholds a lower court's ruling and offers no guidance for lower courts.
While the Supreme Court does not make public...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!